| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and CEO | President and CEO
1 company
Lowenthal Richard E serves as a President and CEO at SPRY. Across recent SEC filings that breaks down to 0 buys and 73 sells. Those positions are worth an estimated $17.3M at current prices.
Historically, Lowenthal Richard E's trades have earned a middling insider score of 54/100 across 31 rated trades. Over a 12-month horizon, 30.0% of those trades were profitable, with an average 12-month return of -21.7%.
The biggest single holding is SPRY (~$17.3M) as President and CEO. The recent filings there lean toward selling, a net 2,053,260 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 21, 2025 | SPRY Ars Pharmaceuticals, Inc. | President and CEO | Sell | 50,000 | $14.49 | $724,345.00 | -4.0% | -52.3% | -63.0% | |
| Dec 17, 2024 | SPRY Ars Pharmaceuticals, Inc. | President and CEO | Sell | 100,000 | $11.67 | $1,167,100.00 | -8.3% | -2.7% | -14.4% | |
| Dec 10, 2024 | SPRY Ars Pharmaceuticals, Inc. | President and CEO | Sell | 100,000 | $13.16 | $1,316,420.00 | -8.0% | -16.4% | -19.4% | |
| Nov 19, 2024 | SPRY Ars Pharmaceuticals, Inc. | President and CEO | Sell | 100,000 | $13.95 | $1,394,960.00 | -7.7% | -14.6% | -48.6% | |
| Nov 12, 2024 | SPRY Ars Pharmaceuticals, Inc. | President and CEO | Sell | 100,000 | $16.85 | $1,684,642.45 | -7.4% | -29.3% | -46.1% | |
| Oct 15, 2024 | SPRY Ars Pharmaceuticals, Inc. | President and CEO | Sell | 100,000 | $14.88 | $1,487,595.07 | -7.2% | -26.1% | -28.0% | |
| Oct 8, 2024 | SPRY Ars Pharmaceuticals, Inc. | President and CEO | Sell | 100,000 | $13.83 | $1,382,775.00 | -6.9% | -20.2% | -20.0% | |
| Sep 17, 2024 | SPRY Ars Pharmaceuticals, Inc. | President and CEO | Sell | 100,000 | $12.93 | $1,293,205.00 | -6.7% | -8.9% | -26.7% | |
| Sep 10, 2024 | SPRY Ars Pharmaceuticals, Inc. | President and CEO | Sell | 100,000 | $11.50 | $1,149,775.00 | -6.5% | +15.6% | -8.8% | |
| Aug 20, 2024 | SPRY Ars Pharmaceuticals, Inc. | President and CEO | Sell | 100,000 | $15.03 | $1,502,586.52 | -6.3% | -7.5% | -1.9% |